Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
White willow bark contains salicin, which converts to salicylic acid in the body and inhibits cyclooxygenase enzymes to reduce inflammation and pain. This natural source of aspirin-like compounds has been used for centuries to treat headaches, arthritis, and fever.
Reported Benefits (Provisional)
Origin & History
White Willow Bark, derived from the Salix Alba tree, is native to Europe and Asia. The bark is harvested and processed to extract salicin, the active compound.
Research Narrative (Provisional)
Clinical trials have demonstrated its efficacy in reducing pain and inflammation, similar to aspirin. Meta-analyses confirm its safety and effectiveness.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains salicin, a precursor to aspirin. - Rich in polyphenols and flavonoids. - Provides tannins and phenolic acids.
Reported Mechanism (Provisional)
Salicin, the primary bioactive compound in white willow bark, is metabolized to salicylic acid in the liver and intestines. This salicylic acid selectively inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, reducing prostaglandin E2 synthesis. Additional compounds like flavonoids and tannins provide synergistic anti-inflammatory effects through modulation of nuclear factor-kappa B (NF-κB) pathways.
Clinical Narrative (Provisional)
A randomized controlled trial of 210 patients with lower back pain found that 240mg daily of salicin extract reduced pain scores by 39% compared to placebo over 4 weeks. Another study with 78 osteoarthritis patients showed 240mg salicin daily for 2 weeks significantly improved pain and mobility compared to placebo. However, most clinical trials are small-scale and short-term, with limited head-to-head comparisons against conventional NSAIDs. More robust long-term safety and efficacy data is needed.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.